Author(s): О.G. Nefidova, D.V. Babaskin, T.M. Litvinova, L.I. Babaskina, I.U. Glazkova, O.V. Savinova

Email(s): babaskin.d.v@mail.ru

DOI: 10.52711/0974-360X.2024.00420   

Address: О.G. Nefidova1,2, D.V. Babaskin2*, T.M. Litvinova2, L.I. Babaskina2, I.U. Glazkova2, O.V. Savinova2
1Scientific Centre for Expert Evaluation of Medicinal Products, 8-2 Petrovsky Blvd, Moscow, Russian Federation, 127051.
2Sechenov First Moscow State Medical University, 8-2 Trubetskaya St., Moscow, Russian Federation, 119991.
*Corresponding Author

Published In:   Volume - 17,      Issue - 6,     Year - 2024


ABSTRACT:
To perform the urgent tasks of optimizing the procedures for registration of medicines within the framework of the Eurasian Economic Union, it is necessary to analyze and evaluate the current changes made to the Rules for Registration and Examination of Medicines after approval by the Eurasian Economic Commission. The purpose of this paper was to conduct an expert assessment of the main changes made to the Eurasian Economic Commission Rules over the 2022-2023. The assessment was carried out by 38 experts with experience in communication with regulatory bodies on the registration of medicines and making changes to the registration dossier, according to the Likert scale using the developed expert assessment card. It has been established that, in general, experts have a positive attitude to the changes both from the standpoint of their practical significance and the optimal balance of stability and flexibility and in terms of accuracy, correctness, and clarity of formulations. Attention is drawn to the insufficient accuracy of some concepts and to the need to reflect all new terms in section II of the Eurasian Economic Commission Rules. The experts have specifically noted the creation of the necessary conditions for the active circulation of orphan medicines, their accelerated use in some individual cases, increasing the availability of unregistered medicines in special cases, ensuring the possibility of obtaining an indefinite registration certificate, and providing a registration dossier only on electronic media,excluding the annual revaluation of the benefit/risk ratio for some medicines, and the acceleration of the mutual recognition procedures in several EAEU member states due to simultaneous initiation. It has been shown that there is a need for a more detailed consideration of changes in the timing of registration and examination procedures for medicines, as well as in the analysis and evaluation of changes in the annexes to the Eurasian Economic Commission Rules. The use of the change management methodology would allow for more consistent and efficient management of amendments to the Eurasian Economic Commission Rules.


Cite this article:
О.G. Nefidova, D.V. Babaskin, T.M. Litvinova, L.I. Babaskina, I.U. Glazkova, O.V. Savinova. Impact of changes in the rules of Registration of medicines by the EAEU on the regulation of the turnover of medicines on its territory. Research Journal of Pharmacy and Technology. 2024; 17(6):2681-8. doi: 10.52711/0974-360X.2024.00420

Cite(Electronic):
О.G. Nefidova, D.V. Babaskin, T.M. Litvinova, L.I. Babaskina, I.U. Glazkova, O.V. Savinova. Impact of changes in the rules of Registration of medicines by the EAEU on the regulation of the turnover of medicines on its territory. Research Journal of Pharmacy and Technology. 2024; 17(6):2681-8. doi: 10.52711/0974-360X.2024.00420   Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-6-39


REFERENCES:
1.    Dogovor o Evraziiskom ekonomicheskom soyuze. Pravovoi portal Evroaziatskogo ekonomicheskogo soyuza [Treaty on the Eurasian Economic Union. Legal portal of the Eurasian Economic Union]. – URL: https://docs.eaeunion.org/docs/ru-ru/0003610/itia_05062014 (access date: 25.07.2023).
2.    Soglashenie o edinykh printsipakh i pravilakh obrashcheniya lekarstvennykh sredstv v ramkakh Evraziiskogo ekonomicheskogo soyuza. Portal obshchikh informatsionnykh resursov i otkrytykh dannykh Evroaziatskoi ekonomicheskoi komissii: Akty v sfere obrashcheniya lekarstvennykh sredstv [Agreement on common principles and rules for the circulation of medicines within the Eurasian Economic Union. Portal of general information resources and open data of the Eurasian Economic Commission: Acts in the field of circulation of medicines]. – URL: https://eec.eaeunion.org/upload/medialibrary/d1b/Sogl_LS_Itog.pdf (access date: 25.07.2023).
3.    Seilkassymova R. Nurmukhankyzy D. Rzabay A. Baktykhozhayev Z. Nessipbayeva I. Environmental Safety and Legal Regulation of Medical Waste Management: International Experience. Journal of Environmental Management and Tourism. 2022; 13(7): 1817–1824
4.    Kuderina A. Kuderin I. Bekezhanov D. Nurbek D. Amreeva I. Environmental and legal regulation of the handling of chemicals. Journal of Environmental Management and Tourism. 2021; 12(2): 371–381. doi.org/10.14505//jemt.v12.2(50).06
5.    Nametova A. Yertleuovaa B. Orynkhanovb K. Semenenkoc MP. Sidikhova B. Murzabayeva K. Dushayevaa L. Ichshanovaa A. Marata M. Evaluation of the antibacterial effect of Artemisia lerchiana compared with various medicines. Brazilian Journal of Biology. 2023; 83: 1-7. doi.org/10.1590/1519-6984.277641.
6.    Nefidova ОG. Babaskin DV. Sazonov AD. Kamaletdinova AA. Analysis of the Main Changes in Assessment and Approval of Medicines for Human Use in the Eurasian Economic Union. Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products. Regulatory Research and Medicine Evaluation. 2022; 12(2): 222-226.
7.    Popov AYu. The main directions of improving the efficiency of regulating the circulation of medical devices within the EAEU. Yuridicheskaya nauka.  2022; 1: 63–67.
8.    Tsomartova FV. Problemy sootnosheniya sistem gosudarstvennoi registratsii lekarstvennykh preparatov i ikh patentnoi okhrany [Problems of correlation between the systems of state registration of medicines and their patent protection]. Pravo. Zhurnal Vysshei shkoly ekonomiki. 2019; 1: 133–157.
9.    Navasardova E. Nutrikhin R. Svidlova K. Zaharin A. Burkin D. EAEU environmental legislation: declaration of principles in union law and problems of de-ecologization at the national level. Revista Juridica. 2023; 4(26). doi.org/10.26668/revistajur.2316-753X.v3i75.5361
10.    Akulin IM. Chesnokova EA. Presnyakov RA. Pryadko AE. Development of national regulation of ehealth in the EAEU. RelaçõesInternacionais do Mundo Atual. 2022; 1(34).
11.    Janarthanan. S. RajuKamaraj. Medical Device regulation in U.S. Research J. Pharm. and Tech 2020; 13(9):4453-4456.
12.    Gavrilova NN. Ratnikova IA. Sadanov AK.Orazymbet SE. Shorabaev EZh. Protasiuk LE. Development of Technology for the production of finished forms of Medicinal probiotics. Research Journal of Pharmacy and Technology. 2023; 16(9): 4093-4. doi: 10.52711/0974-360X.2023.00670
13.    Pravila registratsii i ekspertizy lekarstvennykh sredstv dlya meditsinskogo primeneniya. Portal obshchikh informatsionnykh resursov i otkrytykh dannykh Evroaziatskoi ekonomicheskoi komissii: Akty v sfere obrashcheniya lekarstvennykh sredstv [Rules for registration and examination of medicines for medical use. Portal of general information resources and open data of the Eurasian Economic Commission: Acts in the field of circulation of medicines.]. available on https://docs.eaeunion.org/docs/ru-ru/01411969/cncd_21112016_78
14.    Jain T. Dubey D. Jain V. Dashora K. Regulatory Status of Traditional Medicines in Different Countries: An Overview. Research J. Pharm. and Tech. 2011; 4(7): 1007-1015.
15.    Gupta N. Digital Marketing: Trends, Opportunities, and Challenges. Asian Journal of Management. 2020;11(4):434-440.
16.    Dhananjay DC. Mohit RK. Drug Regulatory Affairs: Short Review. Asian Journal of Research in Pharmaceutical Sciences. 2023; 13(1): 73-6.
17.    Elikbaev KN. Dyatlova MI. Obshchii rynok lekarstvennykh sredstv EAES: analiz tekushchego sostoyaniya i problem razvitiya [Common market of medicines of the EAEU: analysis of the current state and development problems]. Fundamentalnye issledovaniya. 2022; 3: 47-52.
18.    Edinyi reestr zaregistrirovannykh lekarstvennykh sredstv Evraziiskogo ekonomicheskogo soyuza. Portal obshchikh informatsionnykh resursov i otkrytykh dannykh Evroaziatskogo ekonomicheskogo soyuza [Unified register of registered medicines of the Eurasian Economic Union. Portal of general information resources and open data of the Eurasian Economic Union.]. available on https://portal.eaeunion.org/sites/commonprocesses/ru-ru/pages/drugregistrationdetails.aspx
19.    Gavrilova NN. Ratnikova IA. Sadanov AK.Orazymbet SE. Shorabaev EZh. Baimakhanova BB. Protasiuk LE. Determination of the Toxicity and Sensitizing effect of a Therapeutic Probiotic agent against Intestinal and Concomitant human infections. Research Journal of Pharmacy and Technology. 2023; 16(9): 4161-1. doi: 10.52711/0974-360X.2023.00682
20.    Yadav VS. Singh B. Evaluating the Human Rights Perspective on Sustainable Development Goals Accessible Health Coverage. Journal of Law and Sustainable Development. 2023; 11(6): doi: 10.55908/sdgs.v11i6.1254
21.    O vnesenii izmenenii v Pravila registratsii i ekspertizy lekarstvennykh sredstv dlya meditsinskogo primeneniya: Reshenie Soveta Evraziiskoi ekonomicheskoi komissii ot 17 marta 2022 goda N 36. Elektronnyi fond pravovykh i normativno-tekhnicheskikh dokumentov [On amendments to the Rules for registration and examination of medicinal products for medical use: Decision N 36 of the Council of the Eurasian Economic Commission dated March 17, 2022. Electronic fund of legal, regulatory and technical documents]. Available on https://docs.cntd.ru/document/350014244
22.    O vnesenii izmenenii v Pravila registratsii i ekspertizy lekarstvennykh sredstv dlya meditsinskogo primeneniya: Reshenie Soveta Evraziiskoi ekonomicheskoi komissii ot 22 maya 2023 g. N 60. EAES. Evroaziatskii ekonomicheskii soyuz. Pravovoi portal [On amendments to the Rules for registration and examination of medicinal products for medical use: Decision N 60 of the Council of the Eurasian Economic Commission dated May 22, 2023. EAEU. Eurasian Economic Union. Legal portal]. Available on https://docs.eaeunion.org/docs/ru-ru/01040158/err_22062023_60
23.    Ermishina OS. Izmeneniya registratsionnogo dose, zatragivayushchie modul 1, i ikh vzaimosvyaz s protsedurami farmakonadzora [Registration dossier changes affecting module 1 and their relationship to pharmacology vigilance procedures]. Materialy nauchno-prakticheskoi konferentsii "Regulyatornaya praktika i registratsiya lekarstvennykh sredstv (RegLek–2023)" [Proceedings of the research and practice conference "Regulatory practice and registration of medicines (RegLek-2023)"]. 2023; 1: 28-29.
24.    Kosenko VV. Primenenie regulyatornykh mekhanizmov dlya obespecheniya dostupnosti lekarstvennykh sredstv v novykh usloviyakh [Application of regulatory mechanisms to ensure availability of medicines in new conditions]. Materialy nauchno-prakticheskoi konferentsii "Regulyatornaya praktika i registratsiya lekarstvennykh sredstv (RegLek–2023)" [Proceedings of the research and practice conference "Regulatory practice and registration of medicines (RegLek-2023)"]. 2023; 1: 7-9.
25.    Ponomarenko AA. Izmeneniya modulya 3 registratsionnogo dose: analiz oshibok zayavitelei [Changes to module 3 of the registration dossier: analysis of applicant errors]. Materialy nauchno-prakticheskoi konferentsii "Regulyatornaya praktika i registratsiya lekarstvennykh sredstv (RegLek–2023)" [Proceedings of the research and practice conference "Regulatory practice and registration of medicines (RegLek-2023)"]. 2023; 1: 30-31.
26.    Rychikhina EM. Protsedura vneseniya izmenenii po Pravilam EAES: problemy, ozhidaemye izmeneniya normativnoi bazy, perspektivy [The procedure for introducing amendments to the EAEU Rules: problems, expected changes in the regulatory framework, and prospects]. Materialy nauchno-prakticheskoi konferentsii "Regulyatornaya praktika i registratsiya lekarstvennykh sredstv (RegLek–2023)" [Proceedings of the research and practice conference "Regulatory practice and registration of medicines (RegLek-2023)"]. 2023; 1: 17-18.
27.    Rychikhina EM. Tkachenko OG. Privedenie v sootvetstvie s trebovaniyami EAES: preimushchestva, protsedury, ozhidaemye izmeneniya normativnoi bazy, perspektivy [Changes to ensure compliance with the requirements of the EAEU: advantages, procedures, expected changes in the regulatory framework, and prospects]. Materialy nauchno-prakticheskoi konferentsii "Regulyatornaya praktika i registratsiya lekarstvennykh sredstv (RegLek–2023)" [Proceedings of the research and practice conference "Regulatory practice and registration of medicines (RegLek-2023)"]. 2023; 1: 21-22.
28.    GOST R 56041-2014. Conformity assessment. Requirements for certification experts of products, services, processes. Elektronnyi fond pravovykh i normativno-tekhnicheskikh dokumentov [Electronic fund of legal and regulatory documents]. Available on https://docs.cntd.ru/document/1200111498?ysclid=ll7q85e4dy991643265
29.    Vasnetsovoi OA. Babaskina DV. Meditsinskoe i farmatsevticheskoe tovarovedenie. Praktikum [Medical and pharmaceutical goods management. A practical course]. 2017; 324.
30.    Rychikhina EM.Obzor osnovnykh izmenenii Pravil registratsii i ekspertizy EAES, utverzhdennykh resheniem Soveta Evraziiskoi ekonomicheskoi komissii [Review of the main changes to the Rules for registration and examination of the EAEU, approved by the decision of the Council of the Eurasian Economic Commission]. Portal FGBU "Nauchnyi tsentr ekspertizy sredstv meditsinskogo primeneniya" Minzdrava Rossii. Available on https://old.regmed.ru/content/page/FAQ-03
31.    Saba K. Payaam V. Indira P. Moringa oleifera A Boon in Pharmaceutical Market. Research Journal of Pharmacognosy and Phytochemistry. 2023; 15(2): 155-0.
32.    Hiteksha JD. Urvi JC. A Comparative Study of Registration Process of Nutraceuticals in different countries. Research Journal of Science and Technology. 2023; 15(2): 73-0.
33.    Kravchuk AM. Uskorennaya registratsiya lekarstvennykh sredstv dlya meditsinskogo primeneniya: kriterii i osobennosti [Accelerated registration of medicines for medical use: criteria and features]. Materialy nauchno-prakticheskoi konferentsii "Regulyatornaya praktika i registratsiya lekarstvennykh sredstv (RegLek–2023)" [Proceedings of the research and practice conference "Regulatory practice and registration of medicines (RegLek-2023)"]. 2023; 1: 19-20.
34.    Portal FGBU "Nauchnyi tsentr ekspertizy sredstv meditsinskogo primeneniya" Minzdrava Rossii.Provedeno ocherednoe zasedanie Koordinatsionnogo soveta ekspertnykh organizatsii EAES [A regular meeting of the Coordination Council of Expert Organizations of the EAEU was held]. Available on http://www.regmed.ru/news/provedeno-ocherednoe-zasedanie-koordinatsionnogo-soveta-ekspertnykh-organizatsiy-eaes/
35.    Panfilova H. Nemchenko O. Simonian L. Tsurikova O. The Analysis of Organizational Approaches in Drug Registration in the EU, Ukraine, Tajikistan, Turkmenistan and Uzbekistan. Research J. Pharm. and Tech. 2018; 11(5): 1894-1900.
36.    Narayanan ASS. Lakshmi KS. Kamaraj R. An Overview on Good Pharmacovigilance Practices and New Operational Plan Milestones of Eudravigilance in European Union. Research J. Pharm. and Tech. 2020; 13(4): 1793-1798.
37.    Rizak G. Heiko I. Dovzhuk V. Konovalova L. Vlasenko N. Problems of Falsification of Medicinal products in the conditions of the COVID-19 Pandemic: Adaptation of Ukrainian legislation to the norms of the European Union. Research Journal of Pharmacy and Technology. 2023; 16(7): 3511-7.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank


Recent Articles




Tags


Not Available